Pain management patients are seeking regenerative alternatives to long-term medications and repeated steroid injections. Stem cell therapy offers a premium regenerative option that addresses tissue degeneration — not just pain signals — at $3,499 per treatment.
Your patients are tired of managing pain — they want solutions. Repeated steroid injections provide diminishing returns. Long-term medications carry side effects. And surgery isn't always appropriate or desired. There's a gap in the treatment algorithm between conservative management and surgical intervention.
Stem cell injection therapy fills that gap. APEX Injection with BioScaf scaffolding delivers concentrated mesenchymal stem cells directly to the source of pain — degenerative joints, damaged tendons, and inflamed tissue — offering a regenerative approach that targets the underlying condition rather than masking symptoms.
Regenerative therapy for the chronic conditions your patients present with daily.
Osteoarthritis, degenerative joint disease, and chronic joint inflammation. Targeted stem cell injection delivers regenerative cells directly to the affected joint with scaffolding support.
Chronic back pain, neuropathic conditions, and widespread inflammation. Systemic IV stem cell therapy for patients with multi-site or systemic pain presentations.
Patients who've plateaued with PT, medications, and steroid injections. Stem cell therapy offers a regenerative next step before surgical consideration.
Add a premium regenerative option to your pain management algorithm.
We evaluate your pain management practice, patient demographics, and current treatment offerings to design your regenerative program.
Pain-specific stem cell protocols, injection guidance, patient selection criteria, and treatment planning integrated into your existing care pathways.
Materials and communication scripts that help patients understand the regenerative approach and make informed treatment decisions.
Marketing campaigns targeting patients seeking regenerative alternatives for chronic pain conditions in your market.
Stem cell therapy adds a regenerative treatment tier between conservative management and surgery. It's particularly valuable for patients who've plateaued with conventional approaches and want to address underlying tissue damage.
Joint degeneration, chronic tendinopathy, disc disease, and soft tissue inflammation are strong candidates. APEX training covers detailed patient selection to identify ideal candidates within your pain management population.
For appropriate candidates, stem cell injections offer a regenerative alternative that targets tissue repair rather than temporary inflammation suppression. Many patients prefer the regenerative approach for long-term benefit.
Stem cell therapy is currently a cash-pay service not covered by insurance. However, at $3,499 per treatment, many patients view it as a worthwhile investment compared to ongoing medication costs, repeated procedures, and surgical expenses.
Results vary by condition and individual. APEX provides patient education materials that set appropriate expectations for treatment timelines and outcomes.
Your patients want more than pain management — they want regeneration. APEX provides the product, training, and marketing to deliver it. Schedule your call.